- Home
- WHWK vs CEE Comparison
WHWK vs CEE Comparison
Compare WHWK & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WHWK | CEE |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.2M | 114.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WHWK | CEE |
|---|---|---|
| Price | $2.96 | $17.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 153.4K | 22.0K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,384,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $7.80 |
| 52 Week High | $3.77 | $10.32 |
Technical Indicators
Market Signals| Indicator | WHWK | CEE |
|---|---|---|
| Relative Strength Index (RSI) | 64.66 | 53.38 |
| Support Level | $2.46 | $17.03 |
| Resistance Level | $2.77 | $18.10 |
| Average True Range (ATR) | 0.17 | 0.58 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 86.96 | 41.26 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.